Avantor
Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, saw its shares tumble by a staggering 17.4% on Wednesday, October 29, 2025. The precipitous decline followed the release of its
Avantor
Avantor (NYSE: AVTR) is a global leader in providing mission-critical products and services to customers in the life sciences and advanced technology industries. Headquartered in Radnor, Pennsylvania, the company plays a pivotal role in supporting scientific innovation across diverse sectors, from biopharmaceuticals and healthcare to education and government. Avantor'
Avantor
Avantor (NYSE: AVTR) shares have recently experienced a significant and sustained plunge, hitting a 52-week low and reflecting a challenging period for the life sciences company. This sharp decline is a direct consequence of both a widespread market sell-off and a confluence of company-specific issues, sending ripples of concern through